Literature DB >> 20965981

Rabbitpox: a model of airborne transmission of smallpox.

Aysegul Nalca1, Donald K Nichols.   

Abstract

Smallpox is a human disease caused by infection with variola virus, a member of the genus Orthopoxvirus. Although smallpox has been eradicated, concern that it might be reintroduced through bioterrorism has therefore led to intensive efforts to develop new vaccines and antiviral drugs against this disease. Because these vaccines and therapeutics cannot be tested in human trials, it is necessary to test such medical countermeasures in different animal models. Although several orthopoxviruses cause disease in laboratory animals, only rabbitpox virus (RPXV) infection of rabbits shows patterns of natural airborne transmission similar to smallpox. Studies have shown that a smallpox-like disease can be produced in rabbits in a controlled fashion through exposure to a small-particle RPXV aerosol, and rabbitpox spreads from animal to animal by the airborne route in a laboratory setting. This model can therefore be utilized to test drugs and vaccines against variola virus and other aerosolized orthopoxviruses.

Entities:  

Mesh:

Year:  2010        PMID: 20965981     DOI: 10.1099/vir.0.026237-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Authors:  M Shannon Keckler; Mary G Reynolds; Inger K Damon; Kevin L Karem
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

2.  Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.

Authors:  Donald F Smee
Journal:  Future Virol       Date:  2013-09       Impact factor: 1.831

3.  A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.

Authors:  Eric M Mucker; Joseph W Golden; Christopher D Hammerbeck; Jennifer M Kishimori; Michael Royals; Mathew D Joselyn; John Ballantyne; Aysegul Nalca; Jay W Hooper
Journal:  J Virol       Date:  2021-12-01       Impact factor: 6.549

Review 4.  Drug Development against Smallpox: Present and Future.

Authors:  Déborah Delaune; Frédéric Iseni
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.938

5.  Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.

Authors:  Joseph W Golden; Matthew Josleyn; Eric M Mucker; Chien-Fu Hung; Peter T Loudon; T C Wu; Jay W Hooper
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

6.  Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.

Authors:  Susan A Holechek; Karen L Denzler; Michael C Heck; Jill Schriewer; R Mark Buller; Fatema A Legrand; Paulo H Verardi; Leslie A Jones; Tilahun Yilma; Bertram L Jacobs
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

7.  Re-Assembly and Analysis of an Ancient Variola Virus Genome.

Authors:  Chad Smithson; Jacob Imbery; Chris Upton
Journal:  Viruses       Date:  2017-09-08       Impact factor: 5.048

8.  Rabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule.

Authors:  Mark R Perry; Richard Warren; Michael Merchlinsky; Christopher Houchens; James V Rogers
Journal:  Front Cell Infect Microbiol       Date:  2018-10-05       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.